Cocaine and Levamisole Cerebral Toxicity
Ann Neurol 89:1253-1254, Allard, J.,et al, 2021
Imaging Findings After Mechanical Thrombectomy in Acute Ischemic Stroke
Stroke 50:1618-1625, Puntonet, J.,et al, 2019
Clinicopathologic Conference, Neurosarcoidosis
NEJM 374:1966-1975, Case 15-2016, 2016
Radiation Necrosis in Pediatric Patients with Brain Tumors Treated with Proton Radiotherapy
AJNR 36:1572-1578, Kralik, S.F.,et al, 2015
Clinicopathologic Conference, Glioblastonoma, WHO grade IV of IV, with Methylation of the MGMT Promoter
NEJM 366:2112-2120, Case 17-2012, 2012
Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis
NEJM 355:1124-1140, Kappos,L.,et al, 2006
Cliniclopath Conf., Granulomatous Amebic Encephalitis Due to Acanthamoeba
NEJM 355:2678-2689, Case 39-2006, 2006
Clinicopath Conf., Primary Diffuse Large-B-Cell Lymphoma of the Brain
NEJM 352:185-194, Case 1-2005, 2005
A 12-year-old girl with headache and change in mental status
Neurol 90:524-529, Patel, P.,et al, 2018
Infliximab for the Treatment of CNS Sarcoidosis
Neurol 89:2092-2100, Gelfand, J.M.,et al, 2017
Clinicopathologic Conference, Oligdendroglioma II/IV with IDH1 R132H mutation and codelation of 1p and 19q
NEJM 375:2381-2389, Case 38-206, 2016
Magnetic Resonance Imaging of Cerebral Aspergillosis: Imaging and Pathological Correlations
PLoS ONE 11:DOI:10.1371/Journal.pone.0152474, Marzoif, G.,et al, 2016
Radiosurgery for Metastatic Spinal Tumors: Follow-Up MR Findings
AJNR 33:382-387, Hwang,Y.J.,et al, 2012
Natalizumab Plus Interferon Beta -1a for Relapsing Multiple Sclerosis
NEJM 354:911-923,965, Rudick,R.A.,et al, 2006
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
NEJM 354:899-910,965, Polman,C.H.,et al, 2006
Methyl Bromide Intoxication Causes Reversible Symmetric Branstem and Cerebellar MRI Lesions
Neurol 64:1279-1281, Geyer,H.L.,et al, 2005
Randomized Controlled Trial of Interferon-beta-1a in Secondary Progressive MS
Neurol 56:1505-1513, Li,D.K.B.,et al, 2001
The Effect of IFNB-1b on the Evolution of Enhancing Lesions in Secondary Progressive MS
Neurol 57:2185-2190, Brex,P.A.,et al, 2001
Herpes Varicella Zoster Encephalitis in Immunocompromised Patients
Neurol 52:193-195, Weaver,S.,et al, 1999
Interferon-alpha 2a Reduces MRI Disease Activity in Relapsing-Remitting Multiple Sclerosis
Neurol 52:1049-1056, Myhr,K.M.,et al, 1999
Evidence of Interferon B-1a Dose Response In Relapsing-Remitting MS, The OWIMS Study
Neurol 53:679-686, The Once Weekly Interferon for MS Study Group (OWI, 1999
Effect of Steroids on Gd-Enhancing Lesions Before & During Beta Interferon 1a Trtm in Relapsing Remitting MS
Neurol 50:403-406, Gasperini,C.,et al, 1998
White Matter Disease Induced by High-Dose Chemotherapy:MR Imaging & Proton Spectroscopy
AJNR 19:217-221, Brown,M.S.,et al, 1998
A 29-Year-Old Man with Multiple Sclerosis
JAMA 280:1432-1439, Rudick,R.A., 1998
Long-Term Outcomes after Radiosurgery for Acoustic Neuromas
NEJM 339:1426-1433,1471, Kondziolka,D.,et al, 1998
Interferon Beta Results in Immediate Reduction of Contrast-Enhanced MRI Lesions in MS Pts Followed by Weekly MRI
Neurol 48:1446-1448, Calabresi,P.A.,et al, 1997
Treatment of Secondary Progressive Multiple Sclerosis with the Immunomodulator Linomide:Study with Monthly MRI Evaluation
Neurol 47:341-346, Karussis,D.M.,et al, 1996
Linomide Reduces the Rate of Active Lesions in Relapsing-Remitting Multiple Sclerosis
Neurol 47:895-900, Anderson,O.,et al, 1996
A Case-Based Review of Cerebral Venous Infarcts with Perfusion Imaging and Comparision to Arterial Ischemic Stroke
Front Radiol 1:687045, Li, A.Y.,et al, 2021
A 55-Year-Old Woman Presenting with Ataxia and Numbness 1 Year After Ileum Resection
Neurol 93:675-679, Cassano, V.,et al, 2019
Spinal Cord Infarction Because of Spontaneous Vertebral Artery Dissection
Stroke 49:e314-e317, Montalvo, M.,et al, 2018
Autoimmune Post-Herpes Simplex Encephalitis of Adults and Teenagers
Neurol 85:1736-1743, 1730, Armangue, T.,et al, 2015
Hashimotos Encephalopathy: A Report of Three Cases and Relevant Literature Reviews
Int J Clin Exp Med 8:16817-16826, Zhu, Y.,et al, 2015
Value of MRI of the Brain in Patients with Systemic Lupus Erythematosus and Neurologic Disturbance
Neuroradiol 46:15-21, Jennings, J.E.,et al, 2014
Stroke-Like Migraine Attacks after Radiation Therapy (SMART) Syndrome is not Always Completely Reversible: A Case Series
AJNR 34:2298-2303, Black, D.F.,et al, 2013
PML-IRIS in a patient treated with Brentuximab
Neurol 79:2075-2077, Geldern, G.,et al, 2012
Headaches, Delusions, and Catharsis
Lancet 374:1652, Etgen,T.,et al, 2009
Clinical Characteristics and MR Imaging Features of Nonalcoholic Wernicke Encephalopathy
AJNR 29:164-169, Fei,G.-q.,et al, 2008
MRI Outcomes in a Placebo-Controlled Trial of Natalizumab in Relapsing MS
Neurol 68:1390-1401, Miller,D.H.,et al, 2007
Angiography-Negative Primary Central Nervous System Vasculitis in Children
Arthritis Rheum 52:2159-2167, Benseler, S.M.,et al, 2005
A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
NEJM 348:14-23, Miller,D.H.,et al, 2003
Vasogenic Edema in Bickerstaff's Brainstem Encephalitis
Neurol 61:836-838, Weidauer,S.,et al, 2003
Benefit of Interferon B-1a on MSFC Progression in Secondary Progressive MS
Neurol 59:679-687, Cohen,J.A.,et al, 2002
Late Secondary Ischemic Injury in Patients Receiving Intraarterial Thrombolysis
Ann Neurol 52:698-703,695, Kidwell,C.S.,et al, 2002
Multiple Sclerosis and Magnetic Resonance Imaging
Arch Neurol 58:35-36, Racke,M.K.,et al, 2001
Evolution of MR Contrast Enhancement Patterns During the First Week after Acute Ischemic Stroke
AJNR 22:103-111, Karonen,J.O.,et al, 2001
Assessing the Risk of Early Multiple Sclerosis in Patients with Clinically Isolated Syndromes: the Role of a Follow Up MRI
JNNP 70:390-393, Brex,P.A.,et al, 2001
European/Canadian Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of the Effects of Glatiramer Acetate on Magnetic Resonance Imaging-Measured Disease Activity and Burden in Patients wi
Ann Neurol 49:290-297, Comi,G.,et al, 2001
Effect of Early Interferon Treatment on Conversion to Definite Multiple Sclerosis: A Randomised Study
Lancet 357:1576-1582,1547, Comi,G.,et al, 2001